Drug Pricing Reforms Tested In Freewheeling Guangdong Could Be Extended Across China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Pharmaceutical pricing reforms now being tested in the export powerhouse province of Guangdong could be adopted China-wide if they prove successful in balancing the longstanding government goal of making essential drugs affordable for a widening sector of the populace and the newer aim of rewarding innovative drugs with higher price levels
You may also be interested in...
China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
American Chamber In China Calls For Streamlined Regulations For Medical Devices
SHANGHAI- The International Monetary Fund recently forecast that China's economy will surpass America and become the world's largest economy in 2016, which means it is more important than ever for U.S. companies to conduct business in China. But government transparency and a level playing field is still the biggest challenge for U.S. companies to operate in China, according to an April 26 white paper released by the American Chamber of Commerce in China